Phaseline

Targets › PRNP

PRNP (Major prion protein): drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 1; Psychiatry; next expected readout Aug 2029.

Its primary physiological function is unclear. May play a role in neuronal development and synaptic plasticity. (UniProt, P04156)

Open in Phaseline: the race on PRNP, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Broad Institute of MIT and HarvardPrP-siRNA (2439-s4, 2439-exNA)
Divalent siRNA targeting PRNP mRNA
PRNPPhase 1Prion DiseaseAug 2029

Conditions

Prion Disease (1)

Modalities

other (1)

Companies

Broad Institute of MIT and Harvard (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.